1976
DOI: 10.1038/bjc.1976.164
|View full text |Cite
|
Sign up to set email alerts
|

Serum ferritin concentration in early breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
34
0
2

Year Published

1976
1976
1994
1994

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 93 publications
(39 citation statements)
references
References 20 publications
3
34
0
2
Order By: Relevance
“…It also confirms other earlier reports (Marcus & Zinberg, 1975;Jacobs et al, 1976) of high circulating ferritin levels in patients with breast cancer. There are many possible causes of raised serum ferritin levels in malignancy, including increased iron stores, release of ferritin from inflamed tissues and production of ferritin by proliferating tumour cells .…”
Section: Discussionsupporting
confidence: 92%
“…It also confirms other earlier reports (Marcus & Zinberg, 1975;Jacobs et al, 1976) of high circulating ferritin levels in patients with breast cancer. There are many possible causes of raised serum ferritin levels in malignancy, including increased iron stores, release of ferritin from inflamed tissues and production of ferritin by proliferating tumour cells .…”
Section: Discussionsupporting
confidence: 92%
“…2 the distribution of serum ferritin concentrations in the present group of patients is compared with that of normal women and those with early breast cancer (Jacobs et al, 1976) and active rheumatoid arthritis (Bentley and Williams, 1974). It is interesting to note that in both malignant groups many of the abnormally high levels are similar to those found in the non-malignant inflammatory condition.…”
mentioning
confidence: 74%
“…Table 1 summarizes the results of CSF femtin, protein, and glucose measurements in patients of all four groups. Low CSF ferritin concentrations were found in patients with noninflammatory neurologic disease (Group I: mean, 9 +-1 ng/ml; range, [4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] and in patients with malignancy without CNS involvement (Group 111: mean, 8 +-1; range, 1 -15 ng/ml). Increased CSF femtin levels were found in patients with malignancy and CNS involvement (Group IV: mean, 43 -t 1 1 ng/ml; range, 10-2 16) and in patients with inflammatory neurologic disease (Group 11: mean, 62 f 14 ng/ml; range, 5-235).…”
Section: Resultsmentioning
confidence: 99%
“…Group ZIZ: Patients with malignant disease without CNS involvement (24 patients) including acute myeloblastic leukemia (AML) (2), acute lymphoblastic leukemia (ALL) (12), chronic lymphocytic leukemia (I), non-Hodgkin's lymphoma (6), carcinoma of ovary (l), and retinoblastoma (2).…”
Section: Methodsmentioning
confidence: 99%